
Scandinavia Embraces Autonomous Public Transport
Gothenburg, Sweden has launched Scandinavia's first large-scale autonomous bus service as part of a groundbreaking public transport trial. Starting August 2025, Västtrafik's new Route 169 features electric Karsan e-Atak buses operating without drivers between Central Station, Gårda, and Liseberg. During the initial six-month trial period, all rides are completely free to encourage public adoption.
How the Technology Works
The 8-meter buses operate at SAE Level 4 autonomy using sensors from Applied Autonomy, including:
- LiDAR systems with 120-meter 3D detection
- Front radar identifying objects up to 160 meters away
- 360-degree cameras monitoring surroundings
- Precision GPS mapping of the fixed route
A safety operator remains onboard during this trial phase to monitor systems and intervene if needed, though the vehicles are designed to handle all driving tasks independently in designated conditions.
Scandinavian Transport Revolution
This initiative follows successful smaller trials in Stavanger, Norway and Tampere, Finland. The Västra Götaland region-funded project addresses multiple challenges:
- Driver shortages affecting public transport reliability
- Reducing operating costs by up to 50% long-term
- Lowering carbon emissions through electrification
- Improving off-peak service frequency
"We're not replacing drivers, but augmenting our network during staff shortages," explained Västtrafik CEO Lars Backström. "This technology could make sustainable transport viable in lower-density areas."
Public Response and Future Plans
Early riders report excitement mixed with caution. "It felt strange at first, but smoother than human drivers," said commuter Elin Johansson after her free trial ride.
If successful, Gothenburg plans to expand the autonomous network to three additional routes by 2026. Similar initiatives are underway in Stockholm and Copenhagen, positioning Scandinavia at the forefront of driverless public transit innovation.
Drive Sweden research hub will monitor safety data and public acceptance throughout the trial period.